https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-06-01 / Int. J. Oncol. 2003 Jun;22(6):1397-402
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-06-01 / Int. J. Oncol. 2003 Jun;22(6):1397-4022003-06-01 00:00:002019-02-15 09:13:26Hyperthermia improves cellular immune response to human hepatocellular carcinoma subsequent to co-culture with tumor lysate pulsed dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-06-01 / Eur. J. Immunol. 2003 Jun;33(6):1754-62
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-06-01 / Eur. J. Immunol. 2003 Jun;33(6):1754-622003-06-01 00:00:002019-02-15 09:17:52Heat shock factor 1-independent activation of dendritic cells by heat shock: implication for the uncoupling of heat-mediated immunoregulation from the heat shock response
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-06-01 / Poult. Sci. 2003 Jun;82(6):899-906
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-06-01 / Poult. Sci. 2003 Jun;82(6):899-9062003-06-01 00:00:002019-02-15 09:22:26Recombinant Newcastle disease virus as a vaccine vector
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-06-01 / Int. J. Hematol. 2003 Jun;77(5):444-55
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-06-01 / Int. J. Hematol. 2003 Jun;77(5):444-552003-06-01 00:00:002019-02-15 09:25:48Immunotherapy for lymphomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-05-13 / World J Surg 2003 Jun;27(6):640-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-05-13 / World J Surg 2003 Jun;27(6):640-62003-05-13 00:00:002019-02-15 08:39:24Doxorubicin activity is enhanced by hyperthermia in a model of ex vivo vascular perfusion of human colon carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-05-01 / Trends Endocrinol. Metab. 2003 May-Jun;14(4):156-62
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-05-01 / Trends Endocrinol. Metab. 2003 May-Jun;14(4):156-622003-05-01 00:00:002019-02-15 08:53:35Dendritic cell vaccination: new hope for the treatment of metastasized endocrine malignancies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-04-01 / Hematology 2003 Apr;8(2):97-104
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-04-01 / Hematology 2003 Apr;8(2):97-1042003-04-01 00:00:002019-02-15 08:32:45Dendritic cell-based immunotherapy for the treatment of hematological malignancies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-04-01 / Zhonghua Gan Zang Bing Za Zhi 2003 Apr;11(4):206-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-04-01 / Zhonghua Gan Zang Bing Za Zhi 2003 Apr;11(4):206-82003-04-01 00:00:002019-02-15 08:37:55[Clinical research on the treatment effect of autologous dendritic cell vaccine on the patients with chronic hepatitis B]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-04-01 / Clin. Cancer Res. 2003 Apr;9(4):1517-27
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-04-01 / Clin. Cancer Res. 2003 Apr;9(4):1517-272003-04-01 00:00:002003-04-01 00:00:00TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-03-01 / Zhonghua Gan Zang Bing Za Zhi 2003 Mar;11(3):149-52
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-03-01 / Zhonghua Gan Zang Bing Za Zhi 2003 Mar;11(3):149-522003-03-01 00:00:002019-02-15 08:36:26[Immune response of dendritic cells acquiring antigens from apoptotic cholangiocarcinoma cells induced by mitomycin]
